Pfizer CEO: On Track to Give U.S. 120M Doses by End of March

The transcript outlines efforts to expand global production capabilities, including new formulation suites and production sites in Kalamazoo, Groton, and McPherson. It highlights process improvements that have doubled batch sizes and increased yield, reducing production timelines from 110 to 60 days. Thanks to these efforts and support from the Biden administration, the company plans to increase dose shipments from 5 million to over 10 million per week, aiming to deliver 120 million doses by March and 200 million by May.

What new facilities are being added as part of the production expansion?

• Distribution centers in Texas

• Formulation suites in Kalamazoo

• New research labs in New York

• Packaging plants in Florida

Which locations are involved in the increased lipid production?

• Kalamazoo and Groton

• McPherson and New York

• Kalamazoo and Florida

• Groton and Texas

What is one of the key improvements made to the production process?

• Increasing the number of production sites

• Doubling the batch size

• Reducing the number of suppliers

• Tripling the batch size

How much has the production timeline been reduced by?

• 100%

• 50%

• 25%

• 75%

What is the target number of doses to be provided to the US government by the end of May?

• 250 million doses

• 200 million doses

• 150 million doses

• 100 million doses